TyG指数与IR在2型糖尿病认知障碍中的研究进展
Research Progress of TyG Index and IR in Cognitive Impairment of Type 2 Diabetes Mellitus
DOI: 10.12677/ACM.2023.131063, PDF,   
作者: 刘艳梅：青海大学研究生院，青海 西宁；刘 冀：青海大学附属医院老年医学科，青海 西宁
关键词: 甘油三酯–葡萄糖乘积指数；胰岛素抵抗；2型糖尿病；认知障碍；Triglyceride Glucose Index； Insulin Resistance； Type 2 Diabetes Mellitus； Cognitive Impairment
摘要: 胰岛素抵抗(IR)是2型糖尿病(T2DM)的特征，是糖尿病慢性并发症的主要发病机理之一，在并发症到来以前准确识别IR水平至关重要。IR发生机理尚未明确，目前主要是脂质超载和炎症两种观点。甘油三酯–葡萄糖指数(TyG)是经济有效的评估IR的新型指标。近年来，该指数在T2DM、糖尿病肾病、代谢综合征、动脉粥样硬化等多种临床常见疾病中的评估作用得到证实。本文主要针对TyG指数与IR在2型糖尿病相关认知障碍(TDACD)中的研究做一综述，以期为认知障碍进展、并发症防治提供新依据，为临床早期识别和干预提供新思路。
Abstract: Insulin resistance (IR) is a characteristic of type 2 diabetes mellitus (T2DM) and one of the main pathogenesis of chronic diabetes complications. It is important to accurately identify IR levels be-fore the onset of complications. The mechanism of IR is not yet clear, but lipid overload and inflam-mation are the two main ideas. Triglyceride-glucose index (TyG) is an economical and effective new index to evaluate IR. In recent years, the index has been proved to be useful in evaluating many common clinical diseases, such as T2DM, diabetic nephropathy, metabolic syndrome and athero-sclerosis. This paper mainly reviews the studies on TyG index and IR in Type 2 diabetes-related cognitive impairment (TDACD), with a view to providing a new basis for the progression of cognitive impairment and the prevention and treatment of complications, as well as new ideas for early clini-cal identification and intervention.
文章引用：刘艳梅, 刘冀. TyG指数与IR在2型糖尿病认知障碍中的研究进展[J]. 临床医学进展, 2023, 13(1): 415-419. https://doi.org/10.12677/ACM.2023.131063

参考文献

[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
[2] 中华医学会内分泌学分会, 中国成人2型糖尿病降压治疗目标研究工作组. 2型糖尿病患者认知功能障碍防治的中国专家共识[J]. 中华内分泌代谢杂志, 2022, 38(6): 453-464.
[3] Arnold, S.E., Arvanitakis, Z., Macauley-Rambach, S.L., et al. (2018) Brain Insulin Resistance in Type 2 Diabetes and Alzheimer Disease: Concepts and Conundrums. Nature Reviews Neurology, 14, 168-181. [Google Scholar] [CrossRef] [PubMed]
[4] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerre-ro-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[5] Guerrero-Romero, F., Simental-Mendía, L.E., González-Ortiz, M., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Journal of Clinical Endocrinology & Metabolism, 95, 3347-3351. [Google Scholar] [CrossRef] [PubMed]
[6] Lim, J., Kim, J., Koo, S.H. and Kwon, G.C. (2019) Comparison of Tri-glyceride Glucose Index, and Related Parameters to Predict Insulin Resistance in Korean Adults: An Analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLOS ONE, 14, e0212963. [Google Scholar] [CrossRef] [PubMed]
[7] de Cuevillas, B., Alvarez-Alvarez, I., Riezu-Boj, J.I., Na-vas-Carretero, S. and Martinez, J.A. (2021) The Hypertriglyceridemic-Waist Phenotype as a Valuable and Integrative Mirror of Metabolic Syndrome Traits. Scientific Reports, 11, Article No. 21859. [Google Scholar] [CrossRef] [PubMed]
[8] Huanan, C., Sangsang, L., Amoah, A.N., et al. (2020) Relation-ship between Triglyceride Glucose Index and the Incidence of Non-Alcoholic Fatty Liver Disease in the Elderly: A Ret-rospective Cohort Study in China. BMJ Open, 10, e039804. [Google Scholar] [CrossRef] [PubMed]
[9] Jiang, T., Zhou, Y., Zhang, D., et al. (2021) Association of Serum Interleukin-34 and Insulin Resistance with Cognitive Impairment in Patients with Cerebral Small Vessel Disease. Current Neurovascular Research, 18, 446-455. [Google Scholar] [CrossRef] [PubMed]
[10] Yan, Y., Hu, F., Wu, W., Ma, R. and Huang, H. (2017) Expression Characteristics of Proteins of IGF-1R, p-Akt, and Survivin in Papillary Thyroid Carcinoma Patients with Type 2 Diabetes Mellitus. Medicine, 96, e6393. [Google Scholar] [CrossRef] 
[11] Arwert, L.I., Veltman, D.J., Deijen, J.B., et al. (2005) Memory Performance and the Growth Hormone/Insulin-Like Growth Factor Axis in Elderly: A Positron Emission To-mography Study. Neuroendocrinology, 81, 31-40. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, D., Jiang, S. and Meng, H. (2015) Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy. International Journal of Endocrinology, 2015, Article ID: 626019. [Google Scholar] [CrossRef] [PubMed]
[13] Planel, E., Tatebayashi, Y., Miyasaka, T., et al. (2007) Insulin Dysfunc-tion Induces in Vivo Tau Hyperphosphorylation through Distinct Mechanisms. Journal of Neuroscience, 27, 13635-13648. [Google Scholar] [CrossRef] 
[14] Cantley, J. (2014) The Control of Insulin Secretion by Adipokines: Current Evidence for Adipocyte-Beta Cell Endocrine Signalling in Metabolic Homeostasis. Mammalian Genome, 25, 442-454. [Google Scholar] [CrossRef] [PubMed]
[15] Ho, L., Qin, W., Pompl, P.N., et al. (2004) Diet-Induced Insulin Resistance Promotes Amyloidosis in a Transgenic Mouse Model of Alzheimer’s Disease. The FASEB Journal, 18, 902-904. [Google Scholar] [CrossRef] [PubMed]
[16] Correia, S.C., Santos, R.X., Carvalho, C., et al. (2012) Insulin Signaling, Glucose Metabolism and Mitochondria: Major Players in Alzheimer’s Disease and Diabetes Interrelation. Brain Research, 1441, 64-78. [Google Scholar] [CrossRef] [PubMed]
[17] Xie, L., Helmerhorst, E., Taddei, K., et al. (2002) Alzheimer’s β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor. Journal of Neuroscience, 22, Article No. RC221. [Google Scholar] [CrossRef] 
[18] Peng, D., Pan, X., Cui, J., Ren, Y. and Zhang, J. (2013) Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats Is Associated with Cog-nitive Impairment. Cellular Physiology and Biochemistry, 32, 1417-1425. [Google Scholar] [CrossRef] [PubMed]
[19] Poitout, V. and Robertson, R.P. (2008) Glucolipotoxicity: Fuel Excess and Beta-Cell Dysfunction. Endocrine Reviews, 29, 351-366. [Google Scholar] [CrossRef] [PubMed]
[20] Butterfield, D.A., Di Domenico, F. and Barone, E. (2014) Elevated Risk of Type 2 Diabetes for Development of Alzheimer Disease: A Key Role for Oxidative Stress in Brain. Biochimica et Biophysica Acta, 1842, 1693-1706. [Google Scholar] [CrossRef] [PubMed]
[21] Parhofer, K.G. (2015) Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia. Diabetes & Metabolism Journal, 39, 353-362. [Google Scholar] [CrossRef] [PubMed]
[22] Briaud, I., Harmon, J.S., Kelpe, C.L., Segu, V.B.G. and Poitout, V. (2001) Lipotoxicity of the Pancreatic β-Cell Is Associated with Glucose-Dependent Esterification of Fatty Acids into Neutral Lipids. Diabetes, 50, 315-21. [Google Scholar] [CrossRef] [PubMed]
[23] Tran, D.Q., Erika, K.T., Kim, M.H. and Belsham, D.D. (2016) Di-et-Induced Cellular Neuroinflammation in the Hypothalamus: Mechanistic Insights from Investigation of Neurons and Microglia. Molecular and Cellular Endocrinology, 438, 18-26. [Google Scholar] [CrossRef] [PubMed]
[24] Nam, K.-W., Kwon, H.-M., Jeong, H.-Y., et al. (2020) High Tri-glyceride-Glucose Index Is Associated with Subclinical Cerebral Small Vessel Disease in a Healthy Population: A Cross-Sectional Study. Cardiovascular Diabetology, 19, Article No. 53. [Google Scholar] [CrossRef] [PubMed]

为你推荐